Published in Pharmacol Biochem Behav on April 07, 2009
Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety. Mol Psychiatry (2012) 1.03
Increased vulnerability of the brain norepinephrine system of females to corticotropin-releasing factor overexpression. Mol Psychiatry (2012) 0.95
Behavioral Studies and Genetic Alterations in Corticotropin-Releasing Hormone (CRH) Neurocircuitry: Insights into Human Psychiatric Disorders. Behav Sci (Basel) (2012) 0.85
Forebrain-specific CRF overproduction during development is sufficient to induce enduring anxiety and startle abnormalities in adult mice. Neuropsychopharmacology (2013) 0.84
Assessing behavioural effects of chronic HPA axis activation using conditional CRH-overexpressing mice. Cell Mol Neurobiol (2011) 0.84
Cardiac autonomic imbalance by social stress in rodents: understanding putative biomarkers. Front Psychol (2014) 0.82
Site-specific modulation of brain glucocorticoid receptor and corticotropin-releasing hormone expression using lentiviral vectors. Mol Cell Endocrinol (2012) 0.79
Evidence for the role of corticotropin-releasing factor in major depressive disorder. Neurosci Biobehav Rev (2015) 0.77
Overexpression of Forebrain CRH During Early Life Increases Trauma Susceptibility in Adulthood. Neuropsychopharmacology (2015) 0.76
Resilience to the effects of social stress: evidence from clinical and preclinical studies on the role of coping strategies. Neurobiol Stress (2015) 0.76
Hyperactivity of Hypothalamic-Pituitary-Adrenal Axis Due to Dysfunction of the Hypothalamic Glucocorticoid Receptor in Sigma-1 Receptor Knockout Mice. Front Mol Neurosci (2017) 0.75
Epigenetic transmission of the impact of early stress across generations. Biol Psychiatry (2010) 3.55
Protein phosphatase 1 is a molecular constraint on learning and memory. Nature (2002) 2.91
Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy. Nat Rev Drug Discov (2012) 2.44
Systemically delivered antisense oligomers upregulate gene expression in mouse tissues. Nat Biotechnol (2002) 2.38
Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol Med (2010) 2.25
The gamma 2 subunit of GABA(A) receptors is required for maintenance of receptors at mature synapses. Mol Cell Neurosci (2003) 2.18
KAP1-mediated epigenetic repression in the forebrain modulates behavioral vulnerability to stress. Neuron (2008) 2.17
Proteolytic degradation of SCOP in the hippocampus contributes to activation of MAP kinase and memory. Cell (2007) 2.12
Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations. Mol Cell Proteomics (2006) 2.09
Dendritic spine loss and synaptic alterations in Alzheimer's disease. Mol Neurobiol (2008) 2.03
Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry (2007) 1.91
The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence. Brain Res Brain Res Rev (2005) 1.80
Contribution of common genetic variants to antidepressant response. Biol Psychiatry (2012) 1.73
Chronic social stress inhibits cell proliferation in the adult medial prefrontal cortex: hemispheric asymmetry and reversal by fluoxetine treatment. Neuropsychopharmacology (2006) 1.72
Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology (2007) 1.64
Plasma protein biomarkers for depression and schizophrenia by multi analyte profiling of case-control collections. PLoS One (2010) 1.62
Epigenetic codes in cognition and behaviour. Behav Brain Res (2008) 1.56
Imaging dopamine D3 receptors in the human brain with positron emission tomography, [11C]PHNO, and a selective D3 receptor antagonist. Biol Psychiatry (2010) 1.50
Protein phosphatase 1 regulates the histone code for long-term memory. J Neurosci (2009) 1.44
Comprehensive mapping of post-translational modifications on synaptic, nuclear, and histone proteins in the adult mouse brain. J Proteome Res (2009) 1.43
The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection. J Neurosci (2007) 1.38
Reversible and covalent binding of drugs to human serum albumin: methodological approaches and physiological relevance. Curr Med Chem (2002) 1.38
Characterization of divIVA and other genes located in the chromosomal region downstream of the dcw cluster in Streptococcus pneumoniae. J Bacteriol (2003) 1.36
Control of the establishment of aversive memory by calcineurin and Zif268. Nat Neurosci (2008) 1.36
NCS-1 in the dentate gyrus promotes exploration, synaptic plasticity, and rapid acquisition of spatial memory. Neuron (2009) 1.29
Neural mechanisms of stress resilience and vulnerability. Neuron (2012) 1.29
Abeta oligomer-mediated long-term potentiation impairment involves protein phosphatase 1-dependent mechanisms. J Neurosci (2007) 1.28
Oxidative stress-related biomarkers in autism: systematic review and meta-analyses. Free Radic Biol Med (2012) 1.24
Influence of early stress on social abilities and serotonergic functions across generations in mice. PLoS One (2011) 1.22
Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis. PLoS Med (2012) 1.19
Phage-display and correlated mutations identify an essential region of subdomain 1C involved in homodimerization of Escherichia coli FtsA. Proteins (2003) 1.17
Drug binding to human serum albumin: abridged review of results obtained with high-performance liquid chromatography and circular dichroism. Chirality (2006) 1.16
Identification of combinatorial patterns of post-translational modifications on individual histones in the mouse brain. PLoS One (2012) 1.15
Epigenetic inheritance in mammals: evidence for the impact of adverse environmental effects. Neurobiol Dis (2009) 1.14
A central role for the small GTPase Rac1 in hippocampal plasticity and spatial learning and memory. Mol Cell Neurosci (2009) 1.14
Epigenetic dysregulation in cognitive disorders. Eur J Neurosci (2009) 1.13
A crosstalk between β1 and β3 integrins controls glycine receptor and gephyrin trafficking at synapses. Nat Neurosci (2010) 1.11
The role of protein phosphatase-1 in the modulation of synaptic and structural plasticity. FEBS Lett (2004) 1.10
Epigenetic inheritance of disease and disease risk. Neuropsychopharmacology (2012) 1.07
Inducible and neuron-specific gene expression in the adult mouse brain with the rtTA2S-M2 system. Genesis (2005) 1.04
Neural functions of calcineurin in synaptic plasticity and memory. Learn Mem (2012) 1.03
Anxiolytic-like effect of the selective neuropeptide Y Y2 receptor antagonist BIIE0246 in the elevated plus-maze. Peptides (2006) 1.03
Effects of fluoxetine on behavioral deficits evoked by chronic social stress in rats. Behav Brain Res (2006) 1.03
A comparative study of the effects of the intravenous self-administration or subcutaneous minipump infusion of nicotine on the expression of brain neuronal nicotinic receptor subtypes. Mol Pharmacol (2010) 1.03
Early life epigenetic programming and transmission of stress-induced traits in mammals: how and when can environmental factors influence traits and their transgenerational inheritance? Bioessays (2014) 1.03
Brain fMRI reactivity to smoking-related images before and during extended smoking abstinence. Exp Clin Psychopharmacol (2009) 1.02
NMDA-induced potentiation of mGluR5 is mediated by activation of protein phosphatase 2B/calcineurin. Neuropharmacology (2005) 1.02
1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonists. J Med Chem (2007) 1.02
Reversible blockade of experience-dependent plasticity by calcineurin in mouse visual cortex. Nat Neurosci (2005) 1.00
Inheritable effect of unpredictable maternal separation on behavioral responses in mice. Front Behav Neurosci (2011) 1.00
Systemic administration of ghrelin increases extracellular dopamine in the shell but not the core subdivision of the nucleus accumbens. Neurochem Int (2008) 0.98
Dynamic histone marks in the hippocampus and cortex facilitate memory consolidation. Nat Commun (2012) 0.98
Different susceptibility to social defeat stress of BalbC and C57BL6/J mice. Behav Brain Res (2010) 0.97
Lamotrigine as add-on therapy in schizophrenia: results of 2 placebo-controlled trials. J Clin Psychopharmacol (2007) 0.97
Collybistin is required for both the formation and maintenance of GABAergic postsynapses in the hippocampus. Mol Cell Neurosci (2008) 0.96
Mathematical modelling of [¹¹C]-(+)-PHNO human competition studies. Neuroimage (2012) 0.95
Early-life stress and antidepressants modulate peripheral biomarkers in a gene-environment rat model of depression. Prog Neuropsychopharmacol Biol Psychiatry (2010) 0.95
Chronic stress-induced alterations in amygdala responsiveness and behavior--modulation by trait anxiety and corticotropin-releasing factor systems. Eur J Neurosci (2008) 0.94
Interleaved transcranial magnetic stimulation/functional MRI confirms that lamotrigine inhibits cortical excitability in healthy young men. Neuropsychopharmacology (2004) 0.94
Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania. Behav Brain Res (2005) 0.94
Brain functional connectivity in stimulant drug dependence and obsessive-compulsive disorder. Neuroimage (2011) 0.94
SB-649915-B, a novel 5-HT1A/B autoreceptor antagonist and serotonin reuptake inhibitor, is anxiolytic and displays fast onset activity in the rat high light social interaction test. Neuropsychopharmacology (2007) 0.93
Acoustic over-exposure triggers burst firing in dorsal cochlear nucleus fusiform cells. Hear Res (2011) 0.92
1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonists. J Med Chem (2010) 0.92
Stable expression and functional characterization of a human nicotinic acetylcholine receptor with α6β2 properties: discovery of selective antagonists. Br J Pharmacol (2011) 0.92
Epigenetic marking of sperm by post-translational modification of histones and protamines. Epigenetics Chromatin (2014) 0.92
Protein kinase D controls the integrity of Golgi apparatus and the maintenance of dendritic arborization in hippocampal neurons. Mol Biol Cell (2009) 0.92
Mitochondrial DNA toxicity in forebrain neurons causes apoptosis, neurodegeneration, and impaired behavior. Mol Cell Biol (2010) 0.92
Different phosphatase-dependent mechanisms mediate long-term depression and depotentiation of long-term potentiation in mouse hippocampal CA1 area. Eur J Neurosci (2003) 0.92
Transgenerational epigenetic effects on brain functions. Biol Psychiatry (2012) 0.92
The reinforcing effects of chronic D-amphetamine and morphine are impaired in a line of memory-deficient mice overexpressing calcineurin. Eur J Neurosci (2005) 0.91
Expression analysis of brain-derived neurotrophic factor (BDNF) mRNA isoforms after chronic and acute antidepressant treatment. Brain Res (2004) 0.91
Partial inhibition of PP1 alters bidirectional synaptic plasticity in the hippocampus. Eur J Neurosci (2006) 0.91
Dopamine responsiveness to drugs of abuse: A shell-core investigation in the nucleus accumbens of the mouse. Synapse (2003) 0.91
Circadian profile of peripheral hormone levels in Sprague-Dawley rats and in common marmosets (Callithrix jacchus). In Vivo (2010) 0.90
Peripheral biomarkers of cognitive response to dopamine receptor agonist treatment. Psychopharmacology (Berl) (2010) 0.90
Expression profiling of a genetic animal model of depression reveals novel molecular pathways underlying depressive-like behaviours. PLoS One (2010) 0.90
The effects of the dopamine D₃ receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects. Int J Neuropsychopharmacol (2011) 0.90
Genome-wide analysis of H4K5 acetylation associated with fear memory in mice. BMC Genomics (2013) 0.89
Protein phosphatase 1-dependent bidirectional synaptic plasticity controls ischemic recovery in the adult brain. J Neurosci (2008) 0.89
Social defeat-induced contextual conditioning differentially imprints behavioral and adrenal reactivity: a time-course study in the rat. Physiol Behav (2007) 0.89
Septins: cellular and functional barriers of neuronal activity. Curr Biol (2007) 0.89
Bayesian modelling and ROC analysis to predict placebo responders using clinical score measured in the initial weeks of treatment in depression trials. Br J Clin Pharmacol (2007) 0.89
Modelling placebo response in depression trials using a longitudinal model with informative dropout. Eur J Pharm Sci (2008) 0.89
Strain-specific outcomes of repeated social defeat and chronic fluoxetine treatment in the mouse. Pharmacol Biochem Behav (2010) 0.89
Altered brain functional connectivity in relation to perception of scrutiny in social anxiety disorder. Psychiatry Res (2012) 0.88
Protein phosphatase 1-dependent transcriptional programs for long-term memory and plasticity. Learn Mem (2010) 0.87
Proteome analysis of rat polymorphonuclear leukocytes: a two-dimensional electrophoresis/mass spectrometry approach. Electrophoresis (2002) 0.87
Discovery process and pharmacological characterization of a novel dual orexin 1 and orexin 2 receptor antagonist useful for treatment of sleep disorders. Bioorg Med Chem Lett (2011) 0.86
Selectivity of d[Cha4]AVP and SSR149415 at human vasopressin and oxytocin receptors: evidence that SSR149415 is a mixed vasopressin V1b/oxytocin receptor antagonist. Br J Pharmacol (2005) 0.86
Changes in the proteome after neuronal zif268 overexpression. J Proteome Res (2009) 0.86
CRF1 receptor activation increases the response of neurons in the basolateral nucleus of the amygdala to afferent stimulation. Front Behav Neurosci (2008) 0.86
Structural brain changes in patients with recurrent major depressive disorder presenting with anxiety symptoms. J Neuroimaging (2010) 0.86
A scintillation proximity assay amenable for screening and characterization of DNA gyrase B subunit inhibitors. Anal Biochem (2002) 0.85